Skip to product information
1 of 1

GeneBio Systems

Recombinant Coagulation Factor III/Tissue Factor/CD142 Monoclonal Antibody

Recombinant Coagulation Factor III/Tissue Factor/CD142 Monoclonal Antibody

SKU:AN300515P

Regular price £0.00 GBP
Regular price Sale price £0.00 GBP
Sale Sold out
Shipping calculated at checkout.

Size::

Storage:This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.

Shipping:Ice bag

Exp date:12 months

Category ID_II:Primary Antibodies

Category ID_III:Recombinant Antibodies;Monoclonal Antibodies

Abbreviation:F3

Target Synonym:FIII;TFA;Thromboplastin;TF;CD142;Tissue factor;Coagulation factor III;Cf-3;Cf3;F3;Coagulation Factor III

Research Areas:

Conjugation:Unconjugated

Host:Rabbit

Species reactivity:Mouse

Application:WB

Isotype:IgG

Clonality:Monoclonal

Clone NO.:9C12

UNIProt ID:P20352

Accession:

Background:Tissue Factor (TF)/CD142 (Coagulation factor III/Thromboplastin) is a type-I transmembrane glycoprotein that serves as the cell surface receptor and cofactor for blood coagulation factors VII and VIIa, and thus plays a central role in hemostasis and thrombosis (1). The TF:VIIa receptor-ligand complex is widely recognized as the initiator of the extrinsic blood coagulation protease cascade, which ultimately leads to the generation of fibrin and thrombin. A member of the type-II cytokine receptor superfamily, TF has also been shown to engage the PI3K and MAPK signaling cascades upon binding to factor VIIa in order to drive cellular responses such as cell migration, growth, and proliferation. Although the function of TF under physiologic conditions is to coordinate blood clotting in response to tissue damage, TF is implicated in pathologic conditions such as tumorigenesis. Indeed, TF is aberrantly expressed in colorectal cancer, breast cancer, pancreatic cancer, and glioblastoma multiforme. It has been shown to promote tumor angiogenesis, tumor growth, metastasis, and venous thrombosis. Given that TF overexpression is associated with numerous types of solid tumors, it has garnered much attention as a potential therapeutic target.

Concentration:1 mg/mL

Immunogen:Recombinant Mouse Coagulation Factor III/Tissue Factor/CD142/F3 Protein

Buffer:0.2 μm filtered solution in PBS

Purification method:Protein A

Dilution:WB 1:500-1:1000

Calculated MW:33 kDa

ObservedMW:56 kDa

View full details